These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1555878)

  • 1. Phenytoin in end-stage renal disease.
    Kaplan B; Krumlovsky FA
    Int J Artif Organs; 1992 Feb; 15(2):69-70. PubMed ID: 1555878
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic considerations in phenytoin pharmacotherapy: preventing overdoses and underdoses.
    Profeta LM; Bradbury K; Mehl B
    Mt Sinai J Med; 1995 Sep; 62(4):312-4. PubMed ID: 7565857
    [No Abstract]   [Full Text] [Related]  

  • 3. Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer.
    Frenchie D; Bastani B
    Nephrol Dial Transplant; 1998 Mar; 13(3):817-8. PubMed ID: 9550689
    [No Abstract]   [Full Text] [Related]  

  • 4. Accuracy of two equations in determining normalized phenytoin concentrations.
    Mauro LS; Mauro VF; Bachmann KA; Higgins JT
    DICP; 1989 Jan; 23(1):64-8. PubMed ID: 2718487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin sodium (dilantin).
    Noerr B
    Neonatal Netw; 1989 Oct; 8(2):63-5. PubMed ID: 2796935
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. The Phenytoin Trial Group on Canine Epilepsy.
    Overduin LM
    Tijdschr Diergeneeskd; 1992 Apr; 117 Suppl 1():27S-28S. PubMed ID: 1585316
    [No Abstract]   [Full Text] [Related]  

  • 7. [The diffusion of diphenylhydantoin across the cellophane membrane of the artificial kidney in a patient with uremia and epilepsy].
    Desjacques P
    Schweiz Rundsch Med Prax; 1972 Mar; 61(13):418-23. PubMed ID: 5020101
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study.
    Vozeh S; Uematsu T; Aarons L; Maitre P; Landolt H; Gratzl O
    Clin Pharmacokinet; 1988 Feb; 14(2):122-8. PubMed ID: 3359738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding.
    Kitchen D; Smith D
    Seizure; 2001 Jun; 10(4):265-8. PubMed ID: 11466022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study on phenytoin pharmacokinetics in 15 patients with refractory epilepsy].
    Pan SQ; Hu ZX; Cai HS
    Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):290-2, 318. PubMed ID: 1478128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin-rifampin drug interaction in a hypoalbuminemic, renal failure patient: a complex clinical case.
    Van Berkel MA; Hurdle AC; Twilla JD
    Pharmacotherapy; 2013 Jun; 33(6):e96-100. PubMed ID: 23471818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe propylene glycol toxicity secondary to use of anti-epileptics.
    Pillai U; Hothi JC; Bhat ZY
    Am J Ther; 2014; 21(4):e106-9. PubMed ID: 22926232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
    Bissoli F; Gini G; Bosio M; Ceriani R
    Recenti Prog Med; 1996 May; 87(5):227-8. PubMed ID: 8767760
    [No Abstract]   [Full Text] [Related]  

  • 16. Paradoxical seizures in phenytoin toxicity.
    Chua HC; Venketasubramanian N; Tan CB; Tjia H
    Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders].
    Wierzchowiecki M; Swiderczuk A; Dyderski S; Masiakowski J; Jazienicki B
    Kardiol Pol; 1987; 30(9):577-82. PubMed ID: 2447321
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenytoin auto-induction? Case reports.
    Miller R; Bill PL; Du Toit J
    S Afr Med J; 1989 Apr; 75(7):332-3. PubMed ID: 2928882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin monitoring: clinical or scientific?
    Fulton JD; McGovern EM; McCarron BN; Carlile AK
    Scott Med J; 1988 Jun; 33(3):267-8. PubMed ID: 3175605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH on the equilibrium dialysis of phenytoin suspension with and without enteral feeding formula.
    Splinter MY; Seifert CF; Bradberry JC; Tu YH; Allen LV
    JPEN J Parenter Enteral Nutr; 1990; 14(3):275-8. PubMed ID: 2112642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.